Alloplex Biotherapeutics
Blood & Organ Banks · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Trade Ctr Ste 6580, Woburn, Massachu...Phone Number
(857) 272-1214Website
www.alloplexbio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
2
2
2
About Alloplex Biotherapeutics
Alloplex Biotherapeutics is a privately-owned company based in Boston, specializing in cellular immunotherapy for cancer and autoimmunity. They have developed a patented cell-retraining platform called ENLIST, which enhances the immune system's ability to target solid tumors using their lead product, SUPLEXA, a clinically-validated autologous cellular therapy. The company aims to advance their innovative therapies through strategic partnerships and investment, leveraging their strong intellectual property and successful clinical trial results. Alloplex is focused on creating scalable, non-engineered cell therapies that demonstrate robust anti-tumor activity while maintaining patient safety.Explore more
Alloplex Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alloplex Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Alloplex Biotherapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Alloplex Biotherapeutics is spiking on competitors!
Alloplex Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Alloplex Biotherapeutics had a recent Job posting/layoffs
Check if Alloplex Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Alloplex Biotherapeutics launches new products
Earning: See what the market has to say on Alloplex Biotherapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Alloplex Biotherapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Alloplex Biotherapeutics
Compare insights from companies similar to Alloplex Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alloplex Biotherapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Alloplex Biotherapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Alloplex Biotherapeutics.
Alloplex Biotherapeutics Tech Stack
A closer look at the technologies used by Alloplex Biotherapeutics
Alloplex Biotherapeutics News & Media
Breakthrough Australian Cancer trial: retraining immune cells offers new hope for patients
ADELAIDE, Australia and BOSTON, Oct. 31, 2024 /PRNewswire/ -- In a remarkable development for cancer research, Australian patients with advanced-stage cancer have benefited from SUPLEXA, a personalised treatment that trains the patient's own immune cells to fight cancer. "Cancer often gains the upper hand by suppressing the immune system. Our approach flips the script: we isolate immune cells from this suppressive environment, we reactivate their inherent cancer-fighting abilities in a laboratorHackensack Meridian Health's Bear's Den Supports Company Developing Novel Way to 'Train' Patients' Own White Blood Cells
BOSTON and EDISON, N.J., Dec. 15, 2021 /PRNewswire/ -- Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is proud to announce its support of the clinical development of a highly-differentiated immuno-oncology platform by Boston-based Alloplex...Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics
- Accelerating development of Alloplex's lead program, SUPLEXA Therapeutic Cells, the next generation tumor agnostic cellular therapy for treating solid and liquid tumors. SEOUL, South Korea, Aug. 19, 2021 /PRNewswire/ -- Daewoong Pharmaceutical and Hanall Biopharma of South Korea are...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alloplex Biotherapeutics
Sign Up For FreeTo access detailed company insights
Alloplex Biotherapeutics is a privately-owned company based in Boston, specializing in cellular immunotherapy for cancer and autoimmunity. They have developed a patented cell-retraining platform called ENLIST, which enhances the immune system's ability to target solid tumors using their lead product, SUPLEXA, a clinically-validated autologous cellu... Read More
